LLY · Lilly(Eli) & Co
United States · RS rating 97 · As of 2026-11-03
| Price | 1,409.38 USD |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 95 / 90 / 89 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 53 / 77 / 60 |
| Industry group (rank) | Medical-Diversified (4) |
| EPS growth Q/Q | +19.0% |
| Sales growth Q/Q | +9.6% |
| Distance from 52-week high | +0.6% |
| Market cap (USD) | $819.8B |